ConductScience.org, home

Trial · NCT02481219

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

NCT02481219, Not applicable, Completed, Medtronic - MITG; results first posted 2016-07-11

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure. Trials, record NCT02481219. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02481219

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
NCT number
NCT02481219
Status
Completed
Phases
Not applicable
Enrollment
122 participants, actual
Lead sponsor
Medtronic - MITG
Conditions
Colorectal Cancer Screening
Interventions
PillCam® COLON 2 procedure-CONTROL, Senna tablets, PEG, Metoclopramide, Erythromycin, SUPREP oral sulfate solution, Bisacodyl, SUPREP oral sulfate solution with Gastrografin
First posted
2015-06-25
Last updated
2017-03-07
Results first posted
2016-07-11

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Within two weeks of study procedure
The primary endpoint is the bowel cleansing level, as determined by a standardized 4-point grading scale, assessed in total and by segment (cecum, ascending, transverse, descending/sigmoid, and rectum).
SecondaryComparing Polyp Detection Rate of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureWill be assessed from RAPID video in total and by segment
SecondaryColonic Transit Time of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureColonic transit time of two different bowel preparation was assessed from RAPID video in total and by segment
SecondaryComparing of Completion Rate of Capsule of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureWill be assessed from RAPID video in total and by segment
SecondaryExcretion Rate of Capsule Within 12 Hours of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureWill be assesses by applicable case report form (CRF)
SecondaryAdverse Events Rate Between Two Different Bowel Preparation Methods for PillCam CCEAdverse Events (AE) were collected starting from the screening visit and until 5-9 days following the PillCam procedure day.Will be assesses by applicable CRF

Outcomes6

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYBowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Within two weeks of study procedurethis was calculated on the per protocol analysis (PPAS) set excluding patients with one (or more) unseen segment in Cecum, Ascending and Transverse colon.percentage of particpantsNUMBER
SECONDARYComparing Polyp Detection Rate of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureThis analysis is a subset of the PPAs excluding patients with one or more missing video data for Cecum, Ascending and transverse colon. Patients with at least one polyp detected on overall segments.percentage of participantsNUMBER
SECONDARYColonic Transit Time of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedureThe following patients were excluded from the analysis:2 withdrawn patients, 1 LTF (Lost to follow-up) patient, 2 pattients with failed prcedure, 16 patients with incomplete COLON exam.hoursMEDIAN
SECONDARYComparing of Completion Rate of Capsule of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedurePer protocol analysis setpercentage of participantsNUMBER
SECONDARYExcretion Rate of Capsule Within 12 Hours of Two Different Bowel Preparation Methods for PillCam CCEan expected average of 3 weeks from study procedure
PPAS: Subjects withdrawn prior to the PillCam procedure (3) and subjects with one or more of the following protocol deviations (13) have been excluded: Evening PEG intake \<1h and \> 2.15h, Morning PEG intake \<1h and \>2:15 h, Capsule ingestion l\<45 min or \>75 min after PEG intake , Overall PEG intake volume is less than 3 liters
percentage of participantsNUMBER
SECONDARYAdverse Events Rate Between Two Different Bowel Preparation Methods for PillCam CCEAdverse Events (AE) were collected starting from the screening visit and until 5-9 days following the PillCam procedure day.Full analysis setpercentage of participants with >1 AENUMBER

Results by group92

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen -ControlOverall Excellent cleansing6.8percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen-TestOverall Excellent cleansing16.7percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen -ControlCecum Excellent cleansing14.0percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen-TestCecum Excellent cleansing14.6percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen -ControlAscending Excellent cleansing12.2percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen-TestAscending Excellent cleansing18.2percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen -ControlTransverse Excellent cleansing10.6percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen-TestTransverse Excellent cleansing14.6percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen -ControlDescending Excellent cleansing9.5percentage of particpants
Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Bowel Preparation Regimen-TestDescending Excellent cleansing18.5percentage of particpants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDBowel Preparation Regimen -Control60
Overall StudySTARTEDBowel Preparation Regimen-Test62
Overall StudyCOMPLETEDBowel Preparation Regimen -Control58
Overall StudyCOMPLETEDBowel Preparation Regimen-Test61
Overall StudyNOT COMPLETEDBowel Preparation Regimen -Control2
Overall StudyNOT COMPLETEDBowel Preparation Regimen-Test1

Adverse events24

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherabdominal painGastrointestinal disordersBowel Preparation Regimen -Control2593
otherabdominal painGastrointestinal disordersBowel Preparation Regimen-Test1621
otherIrritationGeneral disordersBowel Preparation Regimen -Control0590
otherIrritationGeneral disordersBowel Preparation Regimen-Test2622
otherMuscle strainInjury, poisoning and procedural complicationsBowel Preparation Regimen -Control0590
otherMuscle strainInjury, poisoning and procedural complicationsBowel Preparation Regimen-Test1621
otherDiarrhoeaGastrointestinal disordersBowel Preparation Regimen -Control0590
otherDiarrhoeaGastrointestinal disordersBowel Preparation Regimen-Test1621
otherDyspesiaGastrointestinal disordersBowel Preparation Regimen -Control0590
otherDyspesiaGastrointestinal disordersBowel Preparation Regimen-Test1621

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityBowel Preparation Regimen -Control
Total, all-cause mortalityBowel Preparation Regimen-Test
Total, other adverse eventsBowel Preparation Regimen -Control259
Total, other adverse eventsBowel Preparation Regimen-Test1262
Total, serious adverse eventsBowel Preparation Regimen -Control059
Total, serious adverse eventsBowel Preparation Regimen-Test162

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Bowel Preparation Regimen -Control vs Bowel Preparation Regimen-Test: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02481219

GET https://conductscience.org/api/trials/v1/NCT02481219/results?page=2